|
Market Closed -
Nasdaq
00:00:00 29/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 18.27 USD | +2.47% |
|
+6.84% | +46.75% |
| 09-28 | Zymeworks Completes Acquisition of Theravance Biopharma; Updates 2026 Guidance | MT |
| 09-28 | Mylan seeks to clear patent obstacle for generic Wegovy | FW |
| Market Cap | 20.98B 18.46B 17.45B 15.83B 29.73B 2,014B 29.9B 209B 80.7B 1,028B 78.79B 77.08B 3,303B | P/E 2026 * |
78.6x | P/E 2027 * | 45x |
|---|---|---|---|---|---|
| Enterprise Value | 32.94B 28.97B 27.39B 24.84B 46.66B 3,162B 46.93B 328B 127B 1,613B 124B 121B 5,184B | EV / Sales 2026 * |
2.23x | EV / Sales 2027 * | 2.11x |
| Free-Float |
91.44% | Yield 2026 * |
2.78% | Yield 2027 * | 2.86% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VTRS | Delayed | |
CBOE
| VTRS | Real-time | |
|
Tradegate
| VIA | Real-time | |
|
Deutsche Boerse AG
| VIA | Delayed | |
|
Xetra
| VIA | Delayed | |
|
Boerse Muenchen
| VIA | Real-time | |
|
London S.E.
| 0A5V | Delayed | |
|
Börse Stuttgart
| VIA | Delayed | |
|
Borsa Italiana
| 1VTRS | End-of-day quote | |
|
Mexican S.E.
| VTRS * | End-of-day quote | |
|
Wiener Boerse
| VTRS | End-of-day quote | |
|
Swiss Exchange
| VTRS | Delayed | |
|
Swiss Exchange
| VTRS | Delayed | |
|
CBOE
| 0A5V | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Viatris Inc.
| 1 day | +2.47% | ||
| 1 week | +6.84% | ||
| Current month | +10.66% | ||
| 1 month | +11.81% | ||
| 3 months | +11.88% | ||
| 6 months | +40.00% | ||
| Current year | +46.75% |
| 1 week | 16.99 |  | 18.37 |
| 1 month | 16.12 | | 18.37 |
| Current year | 12.19 | | 18.39 |
| 1 year | 9.55 | | 18.39 |
| 3 years | 6.85 | | 18.39 |
| 5 years | 6.85 | | 18.39 |
| 10 years | 6.85 | | 47.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Smith
CEO | Chief Executive Officer | 63 | 01/04/2023 |
Paul Campbell
DFI | Director of Finance/CFO | 59 | 08/05/2026 |
Philippe Martin
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Wyllie Cornwell
BRD | Director/Board Member | 78 | 16/11/2020 |
James Kilts
BRD | Director/Board Member | 78 | 16/11/2020 |
JoEllen Dillon
BRD | Director/Board Member | 62 | 16/11/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/08/26 | Exercice | Chief Administrative Officer | 63,631 | 0.0054% | ||
| 30/06/26 | Free | Director | 2,756 | 0.0002% | ||
| 30/06/26 | Free | Director | 2,362 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.47% | +6.84% | +91.91% | +86.24% | 20.48B | |
| +0.11% | +1.71% | +63.52% | +117.61% | 1,055B | |
| +0.27% | +0.92% | +51.33% | +73.35% | 654B | |
| +0.73% | +0.68% | +20.70% | +74.90% | 467B | |
| -1.36% | -2.58% | +40.20% | +42.33% | 348B | |
| +1.34% | +4.53% | +23.37% | +29.55% | 275B | |
| -0.48% | -0.54% | +13.56% | +13.50% | 258B | |
| +0.85% | +6.35% | +53.17% | +54.39% | 224B | |
| +0.85% | +1.10% | +35.78% | +101.82% | 187B | |
| -0.30% | -2.98% | -27.62% | -61.28% | 171B | |
| Average | +0.36% | +1.15% | +36.59% | +53.24% | 365.88B | |
| Weighted average by Cap. | -0.04% | +1.03% | +40.98% | +69.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.79B 13.01B 12.3B 11.16B 20.95B 1,420B 21.07B 147B 56.88B 724B 55.52B 54.32B 2,328B | 15.04B 13.23B 12.51B 11.34B 21.3B 1,443B 21.43B 150B 57.83B 737B 56.46B 55.23B 2,367B |
| Net income | 142M 124M 118M 107M 200M 13.58B 202M 1.41B 544M 6.93B 531M 520M 22.28B | 298M 262M 248M 225M 423M 28.64B 425M 2.97B 1.15B 14.62B 1.12B 1.1B 46.97B |
| Net Debt | 11.95B 10.51B 9.94B 9.02B 16.93B 1,147B 17.03B 119B 45.96B 585B 44.87B 43.9B 1,881B | 10.68B 9.4B 8.89B 8.06B 15.14B 1,026B 15.22B 106B 41.09B 523B 40.11B 39.24B 1,682B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/09/26 | $18.27 | +2.47% | 12,377,188 |
| 25/09/26 | $17.83 | +2.35% | 10,152,781 |
| 24/09/26 | $17.42 | +1.75% | 13,744,670 |
| 23/09/26 | $17.12 | -0.35% | 6,868,587 |
| 22/09/26 | $17.18 | +0.47% | 5,238,439 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VTRS Stock
Select your edition
All financial news and data tailored to specific country editions
